Citation
Zengin, Gokhan, et al. "Euphorbia Denticulata Lam.: a Promising Source of Phyto-pharmaceuticals for the Development of Novel Functional Formulations." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 87, 2017, pp. 27-36.
Zengin G, Uysal A, Aktumsek A, et al. Euphorbia denticulata Lam.: A promising source of phyto-pharmaceuticals for the development of novel functional formulations. Biomed Pharmacother. 2017;87:27-36.
Zengin, G., Uysal, A., Aktumsek, A., Mocan, A., Mollica, A., Locatelli, M., Custodio, L., Neng, N. R., Nogueira, J. M. F., Aumeeruddy-Elalfi, Z., & Mahomoodally, M. F. (2017). Euphorbia denticulata Lam.: A promising source of phyto-pharmaceuticals for the development of novel functional formulations. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 87, 27-36. https://doi.org/10.1016/j.biopha.2016.12.063
Zengin G, et al. Euphorbia Denticulata Lam.: a Promising Source of Phyto-pharmaceuticals for the Development of Novel Functional Formulations. Biomed Pharmacother. 2017;87:27-36. PubMed PMID: 28040595.
TY - JOUR
T1 - Euphorbia denticulata Lam.: A promising source of phyto-pharmaceuticals for the development of novel functional formulations.
AU - Zengin,Gokhan,
AU - Uysal,Ahmet,
AU - Aktumsek,Abdurrahman,
AU - Mocan,Andrei,
AU - Mollica,Adriano,
AU - Locatelli,Marcello,
AU - Custodio,Luisa,
AU - Neng,Nuno R,
AU - Nogueira,José M F,
AU - Aumeeruddy-Elalfi,Zaahira,
AU - Mahomoodally,M Fawzi,
Y1 - 2016/12/29/
PY - 2016/10/11/received
PY - 2016/12/12/revised
PY - 2016/12/16/accepted
PY - 2017/1/4/pubmed
PY - 2017/2/22/medline
PY - 2017/1/2/entrez
KW - Diabetes
KW - Euphorbia denticulata
KW - Molecular docking
KW - Phyto-pharmaceuticals
KW - Polyphenols
SP - 27
EP - 36
JF - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
JO - Biomed Pharmacother
VL - 87
N2 - In this study, Methanolic extracts of Euphorbia denticulata parts (flowers, leaf, stem, and mix of aerial parts) were assessed for a panoply of bioactivities. Inhibitory potential against key enzymes involved in diabetes (α-glucosidase and α-amylase), obesity (pancreatic lipase), neurodegenerative diseases (cholinesterases), and hyperpigmentation (tyrosinase) was evaluated. The antioxidant and antibacterial properties were also assessed. The total phenolic, flavonoid, and phytochemical profile were established using HPLC/DAD and molecular modelling studies on specific target compounds were performed in silico. The flower extract was found to be rich in phenolics and flavonoids, (60.11±1.40mgGAE/g and 42.04±0.16mgRE/g respectively), which tend to correlate with the high radical scavenging activity of this extract (120.34±3.33mgTE/g and 165.42±2.16mgTE/g for DPPH and ABTS respectively). Catechin, epicatechin, gallic acid, p-OH-Benzoic acid, rosmarinic acid, and epigallocatechin gallate, found in significant abundance in the extracts were assessed using molecular modelling with the aim to study their docking properties on a set of six enzymes used in this study. The extracts were moderately effective with MIC values ranging between 1.56 to 6.25mg/ml, but potent growth inhibitors of MRSA strains. Results amassed herein can be used as a stimulus for further studies geared towards the development of novel phyto-pharmaceuticals.
SN - 1950-6007
UR - https://www.unboundmedicine.com/medline/citation/28040595/Euphorbia_denticulata_Lam_:_A_promising_source_of_phyto_pharmaceuticals_for_the_development_of_novel_functional_formulations_
DB - PRIME
DP - Unbound Medicine
ER -